News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
75 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (335)
2 (311)
3 (237)
4 (70)
6 (2)
7 (48)
8 (54)
9 (56)
10 (84)
11 (40)
13 (1)
14 (80)
15 (90)
16 (78)
17 (59)
18 (31)
20 (1)
21 (91)
22 (78)
23 (75)
24 (68)
25 (25)
26 (1)
28 (4)
29 (222)
30 (262)
31 (261)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
24
25
26
28
29
30
31
Policy
Right-To-Try Legislation Clears Congress, Heads to President Trump’s Desk
Two months after a setback in the U.S. House of Representatives, Congress has authorized “right to try” legislation.
May 23, 2018
·
2 min read
·
Alex Keown
BioMidwest
Investors: Making the Case for Pfizer or AbbVie
For investors looking for a big pharma stock, AbbVie and Pfizer are both top choices.
May 23, 2018
·
3 min read
·
Mark Terry
Drug Development
Verrica Pharmaceuticals Set to Launch $86 Million IPO
Verrica Pharmaceuticals, headquartered in West Chester, Pennsylvania, is launching an initial public offering (IPO), hoping to raise $86 million.
May 23, 2018
·
2 min read
·
Mark Terry
Business
Novartis’ AveXis to Build Gene Therapy Factory in Durham, North Carolina
AveXis, a Novartis company based in Illinois, is investing $55 million to build a new manufacturing facility in Durham, North Carolina.
May 23, 2018
·
3 min read
·
Mark Terry
Business
Former Gilead R&D Head Emerges as CEO of Startup Kronos Backed by Gilead Chairman
Two months after walking away from his role as head of R&D and chief scientific officer at Gilead Sciences, Norbert Bischofberger has re-emerged at the helm of startup Kronos Bio, Inc.
May 23, 2018
·
2 min read
·
Alex Keown
Policy
Former Valeant and Philidor Executives Found Guilty in Kickback Scheme
A former Valeant Pharmaceuticals and a former Philidor Rx Services have been found guilty of using a kickback scheme to defraud the company.
May 23, 2018
·
2 min read
·
Alex Keown
Business
Cara Therapeutics Grabs $70 Million Upfront in Licensing Deal for Late-Stage Kidney Disease Drug
Shares of Cara Therapeutics are soaring this morning after the company announced it secured $70 million in cash as part of a licensing agreement with Vifor Fresenius Medical Care Renal Pharma Ltd. (VFMCRP) for the company’s chronic kidney disease treatment Korsuva.
May 23, 2018
·
2 min read
·
Alex Keown
Business
Survey Shows Most Americans Not Familiar with Precision Medicine
Despite the advances in personalized medicine, a new survey of 1,001 Americans shows that the majority are not familiar with the concept.
May 23, 2018
·
3 min read
·
Alex Keown
Drug Development
Merck’s Keytruda Racks Up Another First-Line Treatment, This Time for Lung Cancer
Merck & Co’s anti-PD-1 therapy Keytruda dazzled in its pivotal Phase III KEYNOTE-407 trial.
May 23, 2018
·
3 min read
·
Mark Terry
Business
The University of Chicago Program Links MBA Students and Scientists to Launch Startups
The University of Chicago’s Polsky Center is designed to set business students who have a mind to become entrepreneurs with scientists hoping to turn their research into a beneficial product.
May 23, 2018
·
3 min read
·
Alex Keown
1 of 8
Next
